---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-027229"
form_type: "8-K"
ticker: "CBUS"
cik: "0001705843"
company_name: "Cibus, Inc."
filed_at: "2026-01-28T23:59:59+00:00"
generated_at: "2026-05-16T07:03:22.454442+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cibus Updates Business Outlook in 8-K, Projects >$200M Annual Royalties from Rice Traits

## Summary
- Cibus estimates over $200 million potential annual addressable royalties from Rice herbicide tolerance traits in the US and Latin America.
- Company reduced workforce by approximately 34 full-time employees by December 31, 2025, to streamline focus on Rice program.
- Anticipates annual net cash usage of $30 million or less during 2026 following cost reduction actions.
- Biofragrance products program could reach $20-40 million annual revenue over a long-term horizon, with initial payments received in 2025.
- EU trilogue on New Genomic Techniques positively concluded in December 2025, creating a regulatory path for gene-edited plants.

## SEC filing metadata
- accession: 0001193125-26-027229
- form_type: 8-K
- ticker: CBUS
- cik: 0001705843
- company_name: Cibus, Inc.
- filed_at: 2026-01-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1705843/000119312526027229/0001193125-26-027229-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1705843/000119312526027229/d210187d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-027229
- JSON: https://secwatch.observer/filing/0001193125-26-027229.json
- Plain text: https://secwatch.observer/filing/0001193125-26-027229.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.